Table 2.
Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|
Predictors | Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value |
Age | 0.99 (0.97–1.02) | 0.6 | – | – |
PSA ng/ml | ||||
<10 | Reference | 0.003 | Reference | 0.006 |
10–20 | 1.65 (1.9–2.28) | <0.0001 | 1.64 (1.15–2.34) | <0.0001 |
>20 | 1.84 (1.31–2.57) | 2.02 (1.39–2.95) | ||
Clinical stage | ||||
T1–T2a | Reference | 0.47 | – | – |
T2b | 0.8 (0.45–1.45) | 0.66 | ||
≥T2c | 1.09 (0.75–1.59) | |||
Biopsy GS | ||||
6 | Reference | 0.007 | Reference | 0.019 |
3+4 | 1.7 (1.15–2.5) | <0.0001 | 1.7 (1.09–2.68) | 0.004 |
4+3 | 3.03 (1.77–5.18) | 0.005 | 2.42 (1.33–4.41) | 0.001 |
8 | 1.77 (1.19–2.63) | <0.0001 | 2.19 (1.38–3.47) | <0.0001 |
9–10 | 3.55 (2.28–5.53) | 3.84 (2.31–6.38) | ||
No. of risk factors | ||||
1 risk factor | Reference | <0.0001 | – | – |
2 risk factors | 2.01 (1.5–2.69) | <0.0001 | ||
3 risk factors | 3.58 (2.01–6.38) | |||
% of positive cores | 1.01 (1.01–1.02) | <0.0001 | 1.01 (1–1.02) | 0.001 |
CI, confidence interval.